Last reviewed · How we verify
Benzoyl Peroxide gel
At a glance
| Generic name | Benzoyl Peroxide gel |
|---|---|
| Also known as | 2.5% benzoyl peroxide gel, Acne Medication |
| Sponsor | Chulalongkorn University |
| Drug class | Retinoid [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
- Dry Skin
- Contact dermatitis
- Application site burning
- Application site irritation
- Skin irritation
Key clinical trials
- Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study (PHASE2)
- Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel) (NA)
- Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris
- Auricular Acupressure Combined With Adapalene for the Treatment of Acne Vulgaris (NA)
- Experience With Topical Acne Treatment (EARLY_PHASE1)
- Cutibacterium Acnes: Triple Prevention in Shoulder Operations (NA)
- A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne (PHASE4)
- A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Benzoyl Peroxide gel CI brief — competitive landscape report
- Benzoyl Peroxide gel updates RSS · CI watch RSS
- Chulalongkorn University portfolio CI